| 2026-08-04 | Press release | Lucid Diagnostics to Participate in Upcoming Investor Conferences |
| 2026-05-15 | Presentation | https://ir.pavmed.com/image/PAVM_1Q26_Earnings_Webinar_v1.pdf |
| 2026-05-15 | Press release | PDF |
| 2026-05-01 | Press release | PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 |
| 2026-04-23 | Press release | Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock |
| 2026-04-09 | Press release | Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference |
| 2026-04-02 | Press release | PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio |
| 2026-03-30 | Presentation | Latest Presentation |
| 2026-03-30 | Press release | PDF |
| 2026-02-04 | Press release | PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Sec |
| 2026-01-21 | Press release | Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® |
| 2025-12-30 | Press release | PAVmed Announces Reverse Stock Split |
| 2025-11-20 | Press release | Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree |
| 2025-11-13 | Press release | PDF |
| 2025-10-30 | Press release | PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 |
| 2025-10-29 | Press release | Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 |
| 2025-10-15 | Press release | Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit |
| 2025-10-07 | Press release | PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Str |
| 2025-09-16 | Press release | Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs |
| 2025-09-11 | Press release | Lucid Diagnostics Announces Closing of Public Offering of Common Stock |
| 2025-09-09 | Press release | Lucid Diagnostics Announces Proposed Public Offering of Common Stock |
| 2025-09-05 | Press release | Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 |
| 2025-08-26 | Press release | PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology |
| 2025-08-14 | Press release | PDF |
| 2025-08-05 | Press release | Lucid Diagnostics to Participate in Upcoming Investor Conferences |
| 2025-07-31 | Press release | PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 |
| 2025-07-30 | Press release | PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule |
| 2025-07-30 | Press release | Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 |
| 2025-07-16 | Press release | MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Es |
| 2025-06-24 | Press release | PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing |
| 2025-06-18 | Press release | Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoG |
| 2025-06-03 | Press release | PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensiv |
| 2025-05-27 | Press release | Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes |
| 2025-05-15 | Press release | PDF |
| 2025-05-01 | Press release | PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 |
| 2025-04-30 | Press release | Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 |
| 2025-04-24 | Press release | NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptom |
| 2025-04-11 | Press release | Lucid Diagnostics Announces Closing of Public Offering of Common Stock |
| 2025-04-09 | Press release | Lucid Diagnostics Announces Proposed Public Offering of Common Stock |
| 2025-04-03 | Press release | Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference |